Latest Ibritumomab tiuxetan Stories

2008-09-02 09:00:43

SAN DIEGO, Sept. 2 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. , a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the appointment of Patrick O'Connor, PhD, Vice President, Research, Michael J.

2008-08-21 09:01:14

SOUTH SAN FRANCISCO, Calif., Aug. 21 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. announced today that Christine A. White, M.D. has been appointed to the company's board of directors.

2008-08-05 03:00:11

SEATTLE, Aug. 5 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (the "Company") (Nasdaq: CTIC; MTA) t announced that Craig W. Philips has assumed his role as CTI's new President, and will concentrate on managing the company's drug development and commercial operations.

2008-07-28 18:00:00

THE TOBACCO plant - responsible for millions of cancer cases - may actually offer the means to treat one form of the disease, a study says. US scientists used the plant to "grow" key components of a cancer vaccine.

2008-07-22 03:00:18

SEATTLE, July 22 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the Company has scheduled a meeting with the U.S.

2008-07-18 09:01:12

Biovest, a subsidiary of Accentia, has announced positive data from a pivotal trial of BiovaxID in lymphoma, and the vaccine now stands a good chance of becoming the first therapeutic cancer vaccine to gain approval in the seven major markets.

2008-07-15 21:00:30

SEATTLE, July 15 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.

2008-06-25 03:01:25

By Wahl, Richard L Many of us remember the 1989 film Field of Dreams, starring Kevin Costner. In brief, the main character becomes convinced that a baseball field must be built on his failing farmland. Another character assures him that if he builds it, "they" will come.

2008-06-20 03:00:29

SEATTLE, June 20 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; MTA) held a Special Meeting in lieu of the Annual Meeting of Shareholders on Thursday, June 19, 2008 at its headquarters in Seattle.

2008-06-18 12:01:00

Cell Therapeutics has signed an agreement with Bayer Schering Pharma to gain access to Bayer's Phase III Zevalin first-line Indolent trial data.

Word of the Day
  • In medieval musical notation, a sign or neume denoting a shake or trill.
The word 'quilisma' comes from a Greek word meaning 'a roll'.